NCT00272558View on ClinicalTrials.gov

Study of Carboplatin and Vinorelbine in Malignant Pleural Mesothelioma

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Malignant Pleural Mesothelioma
Interventions
DRUG

Carboplatin and Vinorelbine

Trial Locations (1)

2100

Dept. Oncol., Rigshospitalet, Copenhagen

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER

NCT00272558 - Study of Carboplatin and Vinorelbine in Malignant Pleural Mesothelioma | Biotech Hunter | Biotech Hunter